{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:35Z","timestamp":1792788335019,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Estadual Paulista J\u00falio De Mesquita Filho","id":[{"id":"https:\/\/ror.org\/00987cb86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01301-3","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:44:50Z","timestamp":1788889490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosome-Based Drug Delivery Systems in Colorectal Cancer: Current Evidence and Future Perspectives"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7505-7568","authenticated-orcid":false,"given":"Lucas Henrique Domingos","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-7591","authenticated-orcid":false,"given":"Juliana Ferreira","family":"Floriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-0545","authenticated-orcid":false,"given":"Marlus","family":"Chorilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"1301_CR1","unstructured":"Globocan. 2020. In: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/10_8_9-Colorectum-fact-sheet.pdf. Accessed 11 Oct 2025."},{"key":"1301_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44:222\u201336. https:\/\/doi.org\/10.1016\/j.tips.2023.01.003.","journal-title":"Trends Pharmacol Sci"},{"key":"1301_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-020-00757-2","volume":"13","author":"A Poursheikhani","year":"2020","unstructured":"Poursheikhani A, Abbaszadegan MR, Nokhandani N, Kerachian MA. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma. BMC Med Genomics. 2020;13:108. https:\/\/doi.org\/10.1186\/s12920-020-00757-2.","journal-title":"BMC Med Genomics"},{"key":"1301_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121858","volume":"9","author":"V Barresi","year":"2021","unstructured":"Barresi V. Colorectal cancer: from pathophysiology to novel therapeutic approaches. Biomedicines. 2021;9:1858. https:\/\/doi.org\/10.3390\/biomedicines9121858.","journal-title":"Biomedicines"},{"key":"1301_CR5","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/medicina59091646","volume":"59","author":"VA Ionescu","year":"2023","unstructured":"Ionescu VA, Gheorghe G, Bacalbasa N, Chiotoroiu AL, Diaconu C. Colorectal cancer: Fr Ris Fact to Onco. Medicina (Kaunas). 2023;59:1646. https:\/\/doi.org\/10.3390\/medicina59091646.","journal-title":"Medicina (Kaunas)"},{"issue":"14","key":"1301_CR6","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.3390\/ijms25147715","volume":"25","author":"W Zhao","year":"2024","unstructured":"Zhao W, Li K, Li L, Wang R, Lei Y, Yang H, et al. Mesenchymal stem cell-derived EXs as drug delivery vehicles in disease therapy. Int J Mol Sci. 2024;25(14):7715. https:\/\/doi.org\/10.3390\/ijms25147715.","journal-title":"Int J Mol Sci"},{"key":"1301_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0.","journal-title":"Lancet"},{"key":"1301_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021","volume":"12","author":"Q Li","year":"2022","unstructured":"Li Q, Wang D, Ding D, Feng Y, Hou R, Liu D, et al. The role and application of EXs in gastric and colorectal cancer. Front Pharmacol. 2022;12:825475. https:\/\/doi.org\/10.3389\/fphar.2021.","journal-title":"Front Pharmacol"},{"key":"1301_CR9","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3748\/wjg.v29.i10.1569","volume":"29","author":"W Leowattana","year":"2023","unstructured":"Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer. World J Gastroenterol. 2023;29:1569\u201388. https:\/\/doi.org\/10.3748\/wjg.v29.i10.1569.","journal-title":"World J Gastroenterol"},{"issue":"16","key":"1301_CR10","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","volume":"68","author":"B Gy\u00f6rgy","year":"2011","unstructured":"Gy\u00f6rgy B, Szab\u00f3 TG, P\u00e1szt\u00f3i M, P\u00e1l Z, Misj\u00e1k P, Aradi B, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68(16):2667\u201388. https:\/\/doi.org\/10.1007\/s00018-011-0689-3.","journal-title":"Cell Mol Life Sci"},{"issue":"20","key":"1301_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nano14201669","volume":"14","author":"I Gaurav","year":"2024","unstructured":"Gaurav I, Thakur A, Zhang K, Thakur S, Hu X, Xu Z, et al. Peptide-conjugated vascular endothelial extracellular vesicles encapsulating vinorelbine for lung cancer targeted therapeutics. Nanomaterials (Basel). 2024;14(20):1669. https:\/\/doi.org\/10.3390\/nano14201669.","journal-title":"Nanomaterials (Basel)"},{"key":"1301_CR12","doi-asserted-by":"publisher","unstructured":"Singh S, Paul D, Nath V, A R. EXs: current knowledge and future perspectives. Tissue Barriers. 2024; 12:2232248. https:\/\/doi.org\/10.1080\/21688370.2023.2232248.","DOI":"10.1080\/21688370.2023.2232248"},{"key":"1301_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/jev.v2i0.20424","volume":"2","author":"Y Yoshioka","year":"2013","unstructured":"Yoshioka Y, Konishi Y, Kosaka N, Katsuda T, Kato T, Ochiya T. Comparative marker analysis of extracellular vesicles in different human cancer types. J Extracell Vesicles. 2013;2:1\u201310. https:\/\/doi.org\/10.3402\/jev.v2i0.20424.","journal-title":"J Extracell Vesicles"},{"issue":"9","key":"1301_CR14","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Ren L, Li S, Li W, Zheng X, Yang Y, et al. The biology, function, and applications of EXs in cancer. Acta Pharm Sin B. 2021;11(9):2783\u201397. https:\/\/doi.org\/10.1016\/j.apsb.2021.01.001.","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"1301_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.797359","volume":"4","author":"D Rao","year":"2022","unstructured":"Rao D, Huang D, Sang C, Zhong T, Zhang Z, Tang Z. Advances in mesenchymal stem cell-derived EXs as drug delivery vehicles. Front Bioeng Biotechnol. 2022;4(9):797359. https:\/\/doi.org\/10.3389\/fbioe.2021.797359.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"1301_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/pharmaceutics15010021","volume":"15","author":"T Li","year":"2022","unstructured":"Li T, Li X, Han G, Liang M, Yang Z, Zhang C, et al. The therapeutic potential and clinical significance of EXs as carriers of drug delivery system. Pharmaceutics. 2022;15(1):21. https:\/\/doi.org\/10.3390\/pharmaceutics15010021.","journal-title":"Pharmaceutics"},{"issue":"15","key":"1301_CR17","doi-asserted-by":"publisher","first-page":"1407329","DOI":"10.3389\/fendo.2024.1407329","volume":"5","author":"J Zhao","year":"2024","unstructured":"Zhao J, Li W, Chen L, Li M, Deng W. Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis. Front Endocrinol (Lausanne). 2024;5(15):1407329. https:\/\/doi.org\/10.3389\/fendo.2024.1407329.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1301_CR18","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/cancers11060798","volume":"11","author":"C Melzer","year":"2019","unstructured":"Melzer C, Rehn V, Yang Y, B\u00e4hre H, von der Ohe J, Hass R. Taxol-loaded MSC-derived EXs provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells. Cancers (Basel). 2019;11:798. https:\/\/doi.org\/10.3390\/cancers11060798.","journal-title":"Cancers (Basel)"},{"key":"1301_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12964-024-01886-2","volume":"22","author":"R Hass","year":"2024","unstructured":"Hass R, von der Ohe J, Luo T. Human mesenchymal stroma\/stem-like cell-derived taxol-loaded EVs\/EXs transfer anti-tumor microRNA signatures and express enhanced SDF-1-mediated tumor tropism. Cell Commun Signal. 2024;22:506. https:\/\/doi.org\/10.1186\/s12964-024-01886-2.","journal-title":"Cell Commun Signal"},{"key":"1301_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2741\/4087","volume":"18","author":"T Musacchio","year":"2013","unstructured":"Musacchio T, Torchilin VP. siRNA delivery: from basics to therapeutic applications. Front Biosci (Landmark Ed). 2013;18:58\u201379. https:\/\/doi.org\/10.2741\/4087.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1301_CR21","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1021\/jacs.1c00014","volume":"143","author":"T Baladi","year":"2021","unstructured":"Baladi T, Nilsson JR, Gallud A, Celauro E, Gasse C, Levi-Acobas F, et al. Stealth fluorescence labeling for live microscopy imaging of mRNA delivery. J Am Chem Soc. 2021;143:5413\u201324. https:\/\/doi.org\/10.1021\/jacs.1c00014.","journal-title":"J Am Chem Soc"},{"key":"1301_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12195-016-0458-3","volume":"9","author":"CC Chen","year":"2016","unstructured":"Chen CC, Liu L, Ma F, Wong CW, Guo XE, Chacko JV, et al. Elucidation of exosome migration across the blood-brain barrier model in vitro. Cell Mol Bioeng. 2016;9:509\u201329. https:\/\/doi.org\/10.1007\/s12195-016-0458-3.","journal-title":"Cell Mol Bioeng"},{"key":"1301_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040571","volume":"16","author":"M Abdelsalam","year":"2023","unstructured":"Abdelsalam M, Ahmed M, Osaid Z, Hamoudi R, Harati R. Insights into exosome transport through the blood-brain barrier and the potential therapeutical applications in brain diseases. Pharmaceuticals (Basel). 2023;16:571. https:\/\/doi.org\/10.3390\/ph16040571.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1301_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010130","volume":"22","author":"A Malki","year":"2020","unstructured":"Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al Moustafa AE. Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements. Int J Mol Sci. 2020;22:130. https:\/\/doi.org\/10.3390\/ijms22010130.","journal-title":"Int J Mol Sci"},{"key":"1301_CR25","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202303015","volume":"223","author":"J Xia","year":"2024","unstructured":"Xia J, Ma N, Shi Q, Liu QC, Zhang W, Cao HJ, et al. XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis. J Cell Biol. 2024;223:e202303015. https:\/\/doi.org\/10.1083\/jcb.202303015.","journal-title":"J Cell Biol"},{"key":"1301_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12885-020-06784-7","volume":"20","author":"K Mukund","year":"2020","unstructured":"Mukund K, Syulyukina N, Ramamoorthy S, Subramaniam S. Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression. BMC Cancer. 2020;20:317. https:\/\/doi.org\/10.1186\/s12885-020-06784-7.","journal-title":"BMC Cancer"},{"key":"1301_CR27","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3978\/j.issn.2078-6891.2015.077","volume":"6","author":"CN Clarke","year":"2015","unstructured":"Clarke CN, Kopetz ES. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. J Gastrointest Oncol. 2015;6:660\u20137. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.077.","journal-title":"J Gastrointest Oncol"},{"key":"1301_CR28","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.31557\/APJCP.2023.24.11.3665","volume":"24","author":"B Hassani","year":"2023","unstructured":"Hassani B, Alizadeh R, Akouchekian M, SafarnezhadTameshkel F, KarbalaieNiya MH. Mutation analysis of KRAS and BRAF in Iranian colorectal cancer patients: a novel variant in exon 15 of BRAF. Asian Pac J Cancer Prev. 2023;24:3665\u201371. https:\/\/doi.org\/10.31557\/APJCP.2023.24.11.3665.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1301_CR29","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3389\/fimmu.2020.02039","volume":"11","author":"A Lin","year":"2020","unstructured":"Lin A, Zhang J, Luo P. Crosstalk between the MSI status and tumor microenvironment in colorectal cancer. Front Immunol. 2020;11:2039. https:\/\/doi.org\/10.3389\/fimmu.2020.02039.","journal-title":"Front Immunol"},{"issue":"2","key":"1301_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ijc.23508","volume":"123","author":"P Watson","year":"2008","unstructured":"Watson P, Vasen HFA, Mecklin JP, Bernstein I, Aarnio M, J\u00e4rvinen HJ, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer. 2008;123(2):444\u20139. https:\/\/doi.org\/10.1002\/ijc.23508.","journal-title":"Int J Cancer"},{"issue":"13","key":"1301_CR31","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.2147\/CMAR.S304281","volume":"31","author":"J Yu","year":"2021","unstructured":"Yu J, Zhang X, Huang Q, Tan S, Xiong X, Gou H. Rare DNA mismatch repair-related protein loss in patients with intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma and their response to immunotherapy. Cancer Manag Res. 2021;31(13):4283\u201390. https:\/\/doi.org\/10.2147\/CMAR.S304281.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"1301_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc3878","volume":"15","author":"HT Lynch","year":"2015","unstructured":"Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895\u20132015. Nat Rev Cancer. 2015;15(3):181\u201394. https:\/\/doi.org\/10.1038\/nrc3878.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1301_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ng.283","volume":"41","author":"MJ Ligtenberg","year":"2009","unstructured":"Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\u2019 exons of TACSTD1. Nat Genet. 2009;41(1):112\u20137. https:\/\/doi.org\/10.1038\/ng.283.","journal-title":"Nat Genet"},{"key":"1301_CR34","doi-asserted-by":"publisher","unstructured":"Walker R, Mahmood K, Como J, Clendenning M, Joo JE, Georgeson P, Joseland S, Preston SG, Pope BJ, Chan JM, Austin R, Bojadzieva J, Campbell A, Edwards E, Gleeson M, Goodwin A, Harris MT, Ip E, Kirk J, Mansour J, Mar Fan H, Nichols C, Pachter N, Ragunathan A, Spigelman A, Susman R, Christie M, Jenkins MA, Pai RK, Rosty C, Macrae FA, Winship IM, Buchanan DD; ANGELS Study. DNA mismatch repair gene variant classification: evaluating the utility of somatic mutations and mismatch repair deficient colonic crypts and endometrial glands. Cancers (Basel). 2023;15(20):4925. https:\/\/doi.org\/10.3390\/cancers15204925.","DOI":"10.3390\/cancers15204925"},{"issue":"4","key":"1301_CR35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10689-023-00334-3","volume":"22","author":"JK Stone","year":"2023","unstructured":"Stone JK, Mehta NA, Singh H, El-Matary W, Bernstein CN. Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome. Fam Cancer. 2023;22(4):413\u201322. https:\/\/doi.org\/10.1007\/s10689-023-00334-3.","journal-title":"Fam Cancer"},{"issue":"4","key":"1301_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-4-22","volume":"12","author":"E Half","year":"2009","unstructured":"Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis. 2009;12(4):22. https:\/\/doi.org\/10.1186\/1750-1172-4-22.","journal-title":"Orphanet J Rare Dis"},{"key":"1301_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2022.101793","author":"AS Aelvoet","year":"2022","unstructured":"Aelvoet AS, Buttitta F, Ricciardiello L, Dekker E. Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights. Best Pract Res Clin Gastroenterol. 2022. https:\/\/doi.org\/10.1016\/j.bpg.2022.101793.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"1301_CR38","doi-asserted-by":"publisher","DOI":"10.1590\/0102-672020180001e1371","volume":"31","author":"GD Souza","year":"2018","unstructured":"Souza GD, Souza LRQ, Cuenca RM, Vilela VM, Santos BEM, Aguiar FS. PRE- AND postoperative imaging methods in colorectal cancer. Arq Bras Cir Dig. 2018;31(2):e1371. https:\/\/doi.org\/10.1590\/0102-672020180001e1371.","journal-title":"Arq Bras Cir Dig"},{"issue":"6","key":"1301_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol. 2019;16(6):361\u201375. https:\/\/doi.org\/10.1038\/s41575-019-0126-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1301_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1007918","volume":"12","author":"G Cui","year":"2022","unstructured":"Cui G, Liu J, Wang C, Gu R, Wang M, Sun Z, et al. Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma. Front Oncol. 2022;12:1007918. https:\/\/doi.org\/10.3389\/fonc.2022.1007918.","journal-title":"Front Oncol"},{"issue":"1","key":"1301_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01491-0","volume":"24","author":"AA Bhat","year":"2024","unstructured":"Bhat AA, Afzal M, Moglad E, Thapa R, Ali H, Almalki WH, et al. LncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer. Clin Exp Med. 2024;24(1):226. https:\/\/doi.org\/10.1007\/s10238-024-01491-0.","journal-title":"Clin Exp Med"},{"key":"1301_CR42","doi-asserted-by":"publisher","first-page":"13696","DOI":"10.3390\/ijms232213696","volume":"23","author":"EM Al-Hujaily","year":"2022","unstructured":"Al-Hujaily EM, Al-Sowayan BS, Alyousef Z, Uddin S, Alammari F. Recruiting immunity for the fight against colorectal cancer: current status and challenges. Int J Mol Sci. 2022;23:13696. https:\/\/doi.org\/10.3390\/ijms232213696.","journal-title":"Int J Mol Sci"},{"key":"1301_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1634\/theoncologist.2019-0176","volume":"25","author":"MA Morse","year":"2020","unstructured":"Morse MA, Hochster H, Benson A. Perspectives on treatment of metastatic colorectal cancer with immune checkpoint inhibitor therapy. Oncologist. 2020;25:33\u201345. https:\/\/doi.org\/10.1634\/theoncologist.2019-0176.","journal-title":"Oncologist"},{"key":"1301_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173819","volume":"893","author":"C Kishore","year":"2021","unstructured":"Kishore C, Bhadra P. Current advancements and future perspectives of immunotherapy in colorectal cancer research. Eur J Pharmacol. 2021;893:173819. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173819.","journal-title":"Eur J Pharmacol"},{"key":"1301_CR45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10120-024-01523-4","volume":"27","author":"A Ooki","year":"2024","unstructured":"Ooki A, Osumi H, Yoshino K, Yamaguchi K. Potent therapeutic strategy in gastric cancer with microsatellite instability-high and\/or deficient mismatch repair. Gastric Cancer. 2024;27:907\u201331. https:\/\/doi.org\/10.1007\/s10120-024-01523-4.","journal-title":"Gastric Cancer"},{"issue":"2","key":"1301_CR46","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/ijms24021337","volume":"24","author":"SV Krylova","year":"2023","unstructured":"Krylova SV, Feng D. The machinery of EXs: biogenesis, release, and uptake. Int J Mol Sci. 2023;24(2):1337. https:\/\/doi.org\/10.3390\/ijms24021337.","journal-title":"Int J Mol Sci"},{"issue":"6478","key":"1301_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of EXs. Science. 2020;367(6478):e6977. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"key":"1301_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","volume":"34","author":"SB Arya","year":"2024","unstructured":"Arya SB, Collie SP, Parent CA. The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol. 2024;34:90\u2013108. https:\/\/doi.org\/10.1016\/j.tcb.2023.06.006.","journal-title":"Trends Cell Biol"},{"issue":"12","key":"1301_CR49","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.2147\/IJN.S135968","volume":"8","author":"LP Brody","year":"2017","unstructured":"Brody LP, Sahuri-Arisoylu M, Parkinson JR, Parkes HG, So PW, Hajji N, et al. Cationic lipid-based nanoparticles mediate functional delivery of acetate to tumor cells in vivo leading to significant anticancer effects. Int J Nanomedicine. 2017;8(12):6677\u201385. https:\/\/doi.org\/10.2147\/IJN.S135968.","journal-title":"Int J Nanomedicine"},{"key":"1301_CR50","doi-asserted-by":"publisher","unstructured":"Farinha, J.O. Pinho, M. Matias, M.M. Gaspar. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs. Drug Deliv Transl Res. 2021;1\u201318, https:\/\/doi.org\/10.1007\/s13346-021-00916-7.","DOI":"10.1007\/s13346-021-00916-7"},{"issue":"3","key":"1301_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15031021","volume":"15","author":"T Boztepe","year":"2023","unstructured":"Boztepe T, Scioli-Montoto S, Gambaro RC, Ruiz ME, Cabrera S, Alem\u00e1n J, et al. Design, synthesis, characterization, and evaluation of the anti-HT-29 colorectal cell line activity of novel 8-oxyquinolinate-platinum(II)-loaded nanostructured lipid carriers targeted with riboflavin. Pharmaceutics. 2023;15(3):1021. https:\/\/doi.org\/10.3390\/pharmaceutics15031021.","journal-title":"Pharmaceutics"},{"issue":"3","key":"1301_CR52","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/polym15030598","volume":"15","author":"Y Riadi","year":"2023","unstructured":"Riadi Y, Afzal O, Geesi MH, Almalki WH, Singh T. Baicalin-loaded lipid-polymer hybrid nanoparticles inhibiting the proliferation of human colon cancer: pharmacokinetics and in vivo evaluation. Polymers (Basel). 2023;15(3):598. https:\/\/doi.org\/10.3390\/polym15030598.","journal-title":"Polymers (Basel)"},{"issue":"2","key":"1301_CR53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","volume":"25","author":"EL Han","year":"2025","unstructured":"Han EL, Tang S, Kim D, Murray AM, Swingle KL, Hamilton AG, et al. Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain. Nano Lett. 2025;25(2):800\u201310. https:\/\/doi.org\/10.1021\/acs.nanolett.4c05186.","journal-title":"Nano Lett"},{"key":"1301_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2020.01.005","volume":"474","author":"D Wang","year":"2020","unstructured":"Wang D, Wang X, Si M, Yang J, Sun S, Wu H, et al. Exosome-encapsulated miRNAs contribute to CXCL12\/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages. Cancer Lett. 2020;474:36\u201352. https:\/\/doi.org\/10.1016\/j.canlet.2020.01.005.","journal-title":"Cancer Lett"},{"key":"1301_CR55","doi-asserted-by":"publisher","unstructured":"Uner B, Akyildiz EO, Kolci K, Reis R. Nanoparticle Formulations for Intracellular Delivery in Colorectal Cancer Therapy. AAPS PharmSciTech. 2025;26(3):81. https:\/\/doi.org\/10.1208\/s12249-025-03069-9. Erratum in: AAPS PharmSciTech. 2025;26(4):104. 10.1208\/s12249-025-03092-w.","DOI":"10.1208\/s12249-025-03069-9"},{"issue":"46","key":"1301_CR56","doi-asserted-by":"publisher","first-page":"43374","DOI":"10.1021\/acsomega.3c04479","volume":"8","author":"L Huang","year":"2023","unstructured":"Huang L, Wu E, Liao J, Wei Z, Wang J, Chen Z. Research advances of engineered exosomes as drug delivery carrier. ACS Omega. 2023;8(46):43374\u201387. https:\/\/doi.org\/10.1021\/acsomega.3c04479.","journal-title":"ACS Omega"},{"issue":"1","key":"1301_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","volume":"31","author":"S Sadeghi","year":"2023","unstructured":"Sadeghi S, Tehrani FR, Tahmasebi S, Shafiee A, Hashemi SM. Exosome engineering in cell therapy and drug delivery. Inflammopharmacology. 2023;31(1):145\u201369. https:\/\/doi.org\/10.1007\/s10787-022-01115-7.","journal-title":"Inflammopharmacology"},{"issue":"18","key":"1301_CR58","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.2147\/IJN.S444582","volume":"23","author":"J Tian","year":"2023","unstructured":"Tian J, Han Z, Song D, Peng Y, Xiong M, Chen Z, et al. Engineered exosome for drug delivery: recent development and clinical applications. Int J Nanomedicine. 2023;23(18):7923\u201340. https:\/\/doi.org\/10.2147\/IJN.S444582.","journal-title":"Int J Nanomedicine"},{"key":"1301_CR59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al. Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release. 2015;207:18\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.033.","journal-title":"J Control Release"},{"issue":"3","key":"1301_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11101-010-9183-z","volume":"9","author":"I Podolak","year":"2010","unstructured":"Podolak I, Galanty A, Sobolewska D. Saponins as cytotoxic agents: a review. Phytochem Rev. 2010;9(3):425\u201374. https:\/\/doi.org\/10.1007\/s11101-010-9183-z.","journal-title":"Phytochem Rev"},{"issue":"8","key":"1301_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.586130","volume":"11","author":"M Xu","year":"2020","unstructured":"Xu M, Yang Q, Sun X, Wang Y. Recent advancements in the loading and modification of therapeutic exosomes. Front Bioeng Biotechnol. 2020;11(8):586130. https:\/\/doi.org\/10.3389\/fbioe.2020.586130.","journal-title":"Front Bioeng Biotechnol"},{"issue":"19","key":"1301_CR62","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.2147\/IJN.S464249","volume":"16","author":"M Bahadorani","year":"2024","unstructured":"Bahadorani M, Nasiri M, Dellinger K, Aravamudhan S, Zadegan R. Engineering exosomes for therapeutic applications: decoding biogenesis, content modification, and cargo loading strategies. Int J Nanomedicine. 2024;16(19):7137\u201364. https:\/\/doi.org\/10.2147\/IJN.S464249.","journal-title":"Int J Nanomedicine"},{"key":"1301_CR63","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1039\/D4NA00501E","volume":"6","author":"SS Palakurthi","year":"2024","unstructured":"Palakurthi SS, Shah B, Kapre S, Charbe N, Immanuel S, Pasham S, et al. A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv. 2024;6:5803\u201326.","journal-title":"Nanoscale Adv"},{"issue":"21","key":"1301_CR64","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S572435","volume":"30","author":"X Ge","year":"2026","unstructured":"Ge X, Shan S, Lu H, Wang W, Gao C, Fu S. Strategies, challenges and application prospects for exosome engineering modifications in tumor targeted therapeutics. Int J Nanomedicine. 2026;30(21):572435. https:\/\/doi.org\/10.2147\/IJN.S572435.","journal-title":"Int J Nanomedicine"},{"key":"1301_CR65","doi-asserted-by":"publisher","first-page":"12376","DOI":"10.3390\/ijms252212376","volume":"25","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yang Y, Lv X, Zhou X, Zhao W, Meng L, et al. Doxorubicin-induced cardiotoxicity through SIRT1 loss potentiates overproduction of EXs in cardiomyocytes. Int J Mol Sci. 2024;25:12376. https:\/\/doi.org\/10.3390\/ijms252212376.","journal-title":"Int J Mol Sci"},{"key":"1301_CR66","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.7150\/ijbs.58786","volume":"17","author":"C Tian","year":"2021","unstructured":"Tian C, Yang Y, Bai B, Wang S, Liu M, Sun RC, et al. Potential of EXs as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity. Int J Biol Sci. 2021;17:1328\u201338. https:\/\/doi.org\/10.7150\/ijbs.58786.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1301_CR67","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12935-025-03689-y","volume":"25","author":"FA Attar","year":"2025","unstructured":"Attar FA, Irani S, Oloomi M, Bolhassani A, Geranpayeh L, Atyabi F. Doxorubicin loaded EXs inhibit cancer-associated fibroblasts growth: in vitro and in vivo study. Cancer Cell Int. 2025;25(1):72. https:\/\/doi.org\/10.1186\/s12935-025-03689-y.","journal-title":"Cancer Cell Int"},{"key":"1301_CR68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.biotechadv.2017.12.010","volume":"36","author":"AA Farooqi","year":"2018","unstructured":"Farooqi AA, Desai NN, Qureshi MZ, Librelotto DRN, Gasparri ML, Bishayee A, et al. Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds. Biotechnol Adv. 2018;36:328\u201334. https:\/\/doi.org\/10.1016\/j.biotechadv.2017.12.010.","journal-title":"Biotechnol Adv"},{"key":"1301_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/molecules29010103","volume":"29","author":"C Ma","year":"2023","unstructured":"Ma C, Ding R, Hao K, Du W, Xu L, Gao Q, et al. Storage stability of blood samples for miRNAs in glycosylated extracellular vesicles. Molecules. 2023;29:103. https:\/\/doi.org\/10.3390\/molecules29010103.","journal-title":"Molecules"},{"issue":"3","key":"1301_CR70","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/biom15030394","volume":"15","author":"AZ Karabay","year":"2025","unstructured":"Karabay AZ, Barar J, Hekmatshoar Y, Rahbar SY. Multifaceted therapeutic potential of plant-derived EXs: immunomodulation, anticancer, anti-aging, anti-melanogenesis, detoxification, and drug delivery. Biomolecules. 2025;15(3):394. https:\/\/doi.org\/10.3390\/biom15030394.","journal-title":"Biomolecules"},{"key":"1301_CR71","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12951-024-02611-4","volume":"22","author":"X Hao","year":"2024","unstructured":"Hao X, Wang S, Wang L, Li J, Li Y, Liu J. EXs as drug delivery systems in glioma immunotherapy. J Nanobiotechnology. 2024;22:340. https:\/\/doi.org\/10.1186\/s12951-024-02611-4.","journal-title":"J Nanobiotechnology"},{"key":"1301_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105835","volume":"179","author":"M Dowaidar","year":"2024","unstructured":"Dowaidar M. Drug delivery based EXs uptake pathways. Neurochem Int. 2024;179:105835. https:\/\/doi.org\/10.1016\/j.neuint.2024.105835.","journal-title":"Neurochem Int"},{"key":"1301_CR73","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","volume":"8","author":"M Zhang","year":"2023","unstructured":"Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z, et al. Engineered EXs from different sources for cancer-targeted therapy. Signal Transduct Target Ther. 2023;8:124. https:\/\/doi.org\/10.1038\/s41392-023-01382-y.","journal-title":"Signal Transduct Target Ther"},{"key":"1301_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215823","volume":"548","author":"Q Tang","year":"2022","unstructured":"Tang Q, Yang S, He G, Zheng H, Zhang S, Liu J, et al. Tumor-derived EXs in the cancer immune microenvironment and cancer immunotherapy. Cancer Lett. 2022;548:215823. https:\/\/doi.org\/10.1016\/j.canlet.2022.215823.","journal-title":"Cancer Lett"},{"key":"1301_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12032-024-02440-3","volume":"41","author":"N Shakerian","year":"2024","unstructured":"Shakerian N, Darzi-Eslam E, Afsharnoori F, Bana N, Noorabad Ghahroodi F, Tarin M, et al. Therapeutic and diagnostic applications of EXs in colorectal cancer. Med Oncol. 2024;41:203.","journal-title":"Med Oncol"},{"key":"1301_CR76","doi-asserted-by":"publisher","first-page":"1101823","DOI":"10.3389\/fonc.2022.1101823","volume":"12","author":"F Xie","year":"2023","unstructured":"Xie F, Huang Y, Zhan Y, Bao L. EXs as drug delivery system in gastrointestinal cancer. Front Oncol. 2023;12:1101823.","journal-title":"Front Oncol"},{"key":"1301_CR77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12929-024-01055-0","volume":"31","author":"YF Chen","year":"2024","unstructured":"Chen YF, Luh F, Ho YS, et al. EXs: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. J Biomed Sci. 2024;31:67\u201377. https:\/\/doi.org\/10.1186\/s12929-024-01055-0.","journal-title":"J Biomed Sci"},{"key":"1301_CR78","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","volume":"29","author":"K Yang","year":"2022","unstructured":"Yang K, Fan M, Wang X, Xu J, Wang Y, Tu F, et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ. 2022;29:133\u201346. https:\/\/doi.org\/10.1038\/s41418-021-00841-9.","journal-title":"Cell Death Differ"},{"key":"1301_CR79","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56:836\u201349. https:\/\/doi.org\/10.1038\/s12276-024-01201-6.","journal-title":"Exp Mol Med"},{"key":"1301_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118369","volume":"261","author":"E Bagheri","year":"2020","unstructured":"Bagheri E, Abnous K, Farzad SA, Taghdisi SM, Ramezani M, Alibolandi M. Targeted doxorubicin-loaded mesenchymal stem cells-derived EXs as a versatile platform for fighting against colorectal cancer. Life Sci. 2020;261:118369.","journal-title":"Life Sci"},{"key":"1301_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113690","volume":"155","author":"NF Hosseini","year":"2022","unstructured":"Hosseini NF, Amini R, Ramezani M, Saidijam M, Hashemi SM, Najafi R. AS1411 aptamer-functionalized EXs in the targeted delivery of doxorubicin in fighting colorectal cancer. Biomed Pharmacother. 2022;155:113690.","journal-title":"Biomed Pharmacother"},{"key":"1301_CR82","doi-asserted-by":"crossref","unstructured":"Huang C, Zhou Y, Feng X, Wang J, Li Y, Yao X. Delivery of engineered primary tumor-derived EXs effectively suppressed the colorectal cancer chemoresistance and liver metastasis. ACS Nano. 2023.","DOI":"10.1021\/acsnano.3c00668"},{"issue":"4","key":"1301_CR83","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/cbdd.14205","volume":"101","author":"R Shekh","year":"2023","unstructured":"Shekh R, Ahmad A, Tiwari RK, Saeed M, Shukla R, Al-Thubiani WS, et al. High therapeutic efficacy of 5-Fluorouracil-loaded exosomes against colon cancer cells. Chem Biol Drug Des. 2023;101(4):962\u201376. https:\/\/doi.org\/10.1111\/cbdd.14205.","journal-title":"Chem Biol Drug Des"},{"key":"1301_CR84","first-page":"2597","volume":"16","author":"D Lin","year":"2022","unstructured":"Lin D, Zhang H, Wang J, et al. iRGD-modified EXs effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation. Mol Oncol. 2022;16:2597\u2013608.","journal-title":"Mol Oncol"},{"issue":"1","key":"1301_CR85","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/10717544.2022.2105444","volume":"29","author":"VD Nguyen","year":"2022","unstructured":"Nguyen VD, Kim HY, Choi YH, Park JO, Choi E. Tumor-derived extracellular vesicles for the active targeting and effective treatment of colorectal tumors in vivo. Drug Deliv. 2022;29(1):2621\u201331. https:\/\/doi.org\/10.1080\/10717544.2022.2105444.","journal-title":"Drug Deliv"},{"issue":"4","key":"1301_CR86","doi-asserted-by":"publisher","first-page":"388","DOI":"10.22038\/IJBMS.2023.68039.14873","volume":"26","author":"E Pishavar","year":"2023","unstructured":"Pishavar E, Yazdian-Robati R, Abnous K, Hashemi M, Ebrahimian M, Feizpour R, et al. Aptamer-functionalized mesenchymal stem cells-derived EXs for targeted delivery of SN38 to colon cancer cells. Iran J Basic Med Sci. 2023;26(4):388\u201394. https:\/\/doi.org\/10.22038\/IJBMS.2023.68039.14873.","journal-title":"Iran J Basic Med Sci"},{"issue":"11-12","key":"1301_CR87","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s10495-024-01986-x","volume":"29","author":"Y Geng","year":"2024","unstructured":"Geng Y, Xia W, Zheng X, Chen L, Zhou Y, Feng J, et al. Targeted delivery of FAK siRNA by engineered exosomes to reverse cetuximab resistance via activating paraptosis in colon cancer. Apoptosis. 2024;29(11\u201312):1959\u201377. https:\/\/doi.org\/10.1007\/s10495-024-01986-x.","journal-title":"Apoptosis"},{"key":"1301_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1310397","volume":"11","author":"R Valente","year":"2023","unstructured":"Valente R, Cordeiro S, Luz A, Melo MC, Rodrigues CR, Baptista PV, et al. Doxorubicin-sensitive and -resistant colorectal cancer spheroid models: assessing tumor microenvironment features for therapeutic modulation. Front Cell Dev Biol. 2023;11:1310397. https:\/\/doi.org\/10.3389\/fcell.2023.1310397.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1301_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01110-y","volume":"31","author":"Z Vakili-Ghartavol","year":"2025","unstructured":"Vakili-Ghartavol Z, Deli H, Shadboorestan A, Sahebnasagh R, Motevaseli E, Ghahremani MH. Exosomes and their distinct integrins transfer the characteristics of oxaliplatin- and 5-FU-resistant behaviors in colorectal cancer cells. Mol Med. 2025;31(1):49. https:\/\/doi.org\/10.1186\/s10020-025-01110-y.","journal-title":"Mol Med"},{"key":"1301_CR90","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.3c00129","author":"H Jia","year":"2023","unstructured":"Jia H, Liu T, Yang Q, Zheng H, Fu S, Hong J, et al. Tumor-derived PD-L1+ EXs with natural inflammation tropism for psoriasis-targeted treatment. Bioconjug Chem. 2023. https:\/\/doi.org\/10.1021\/acs.bioconjchem.3c00129.","journal-title":"Bioconjug Chem"},{"key":"1301_CR91","unstructured":"Study Details | NCT04394572 | Identification of New Diagnostic Protein Markers for Colorectal Cancer | ClinicalTrials.gov [Internet]. [cited 2026 May 26]. https:\/\/clinicaltrials.gov\/study\/NCT04394572?cond=CRC,%20Colorectal%20Cancer&term=exosome&viewType=Card&rank=5. Accessed 26 May 2026."},{"key":"1301_CR92","unstructured":"Study Details | NCT04523389 | Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients | ClinicalTrials.gov [Internet]. [cited 2026 May 26]. https:\/\/clinicaltrials.gov\/study\/NCT04523389?cond=CRC,%20Colorectal%20Cancer&term=exosome&viewType=Card&rank=6. Accessed 26 May 2026."},{"key":"1301_CR93","unstructured":"Study Details | NCT01294072 | Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue | ClinicalTrials.gov [Internet]. [cited 2026 May 26]. https:\/\/clinicaltrials.gov\/study\/NCT01294072?term=exosomes%20drug%20delivery%20cancer%20colorectal&rank=1. Accessed 26 May 2026."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01301-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01301-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01301-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:03:08Z","timestamp":1790665388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01301-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":93,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01301-3","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflicts of interest in this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"134"}}